Estudo revela que Mounjaro da Eli Lilly supera Ozempic da Novo Nordisk em perda de peso

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Estudo revela que Mounjaro da Eli Lilly supera Ozempic da Novo Nordisk em perda de peso

/jornal/2024/07/estudo-revela-que-mounjaro-da-eli-lilly-supera-ozempic-da-novo-nordisk-em-perda-de-peso/

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Lilly Drn Charts.

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Lilly Drn Charts.

News

Real-Time news about Lilly Drn (Brazil Bovespa Exchange): 0 recent articles

More News Articles

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions